1. Hohenester E, Engel J: Domain structure and organisation in extracellular matrix proteins. Matrix Biol 21:115, 2002
2. Hynes RO: The extracellular matrix: Not just pretty fibrils. Science 326:1216, 2009
3. Tsang KY et al: The developmental roles of the extracellular matrix: Beyond structure to regulation. Cell Tissue Res 339:93, 2010
4. Rozario T, DeSimone DW: The extracellular matrix in development and morphogenesis: A dynamic view. Dev Biol 341:126, 2010
5. Ingber D: Tensegrity II. How structural networks influence cellular information processing networks. J Cell Sci 116:1397, 2003
6. Brown AE, Discher DE: Conformational changes and signaling in cell and matrix physics. Curr Biol 19:R781, 2009
7. Buxboim A et al: Matrix elasticity, cytoskeletal forces and physics of the nucleus: How deeply do cells ‘feel’ outside and in? J Cell Sci 123:297, 2010
8. Eckes B, Krieg T: Regulation of connective tissue homeostasis in the skin by mechanical forces. Clin Exp Rheumatol 22:S73, 2004
9. Myllyharju J, Kivirikko KI: Collagens, modifying enzymes and their mutations in humans, flies and worms. Trends Genet 20:33, 2004
10. Heino J: The
collagen family members as cell adhesion proteins.
Bioessays 29:1001, 2007
11. Gordon MK, Hahn RA: Collagens. Cell Tissue Res 339:247, 2010
12. Brodsky B, Persikov AV: Molecular structure of the
collagen triple helix.
Adv Protein Chem 70:301, 2005
13. Myllyharju J, Kivirikko KI: Collagens and collagen-related diseases. Ann Med 33:7, 2001
14. Pulkkinen L et al: Progress in heritable skin diseases: Molecular bases and clinical implications. J Am Acad Dermatol 47:91, 2002
15. Kuivaniemi H et al: Mutations in fibrillar collagens (types I, II, III, and XI), fibril-associated
collagen (type IX), and network-forming
collagen (type X) cause a spectrum of diseases of bone, cartilage, and blood vessels.
Hum Mutat 9:300, 1997
16. Mikkola ML: Molecular aspects of hypohidrotic ectodermal dysplasia. Am J Med Genet A 149A:2031, 2009
17. Bruckner P: Suprastructures of extracellular matrices: Paradigms of functions controlled by aggregates rather than molecules. Cell Tissue Res 339:7, 2010
18. Epstein EH Jr: [a1(3)]
3 human skin
collagen. Release by pepsin digestion and preponderance in fetal life.
J Biol Chem 249:3225, 1974
19. Mitchell AL et al: Molecular mechanisms of classical Ehlers-Danlos syndrome (EDS). Hum Mutat 30:995, 2009
20. Callewaert B et al: Ehlers-Danlos syndromes and Marfan syndrome. Best Pract Res Clin Rheumatol 22:165, 2008
21. Khoshnoodi J et al: Mammalian
collagen IV.
Microsc Res Tech 71:357, 2008
22. Gould DB et al: Role of COL4A1 in small-vessel disease and hemorrhagic stroke. N Engl J Med 354:1489, 2006
23. Hudson BG et al: Alport's syndrome, Goodpasture's syndrome, and type IV
collagen.
N Engl J Med 348:2543, 2003
24. Ghohestani RF et al: The a5 chain of type IV
collagen is the target of IgG autoantibodies in a novel autoimmune disease with subepidermal blisters and renal insufficiency.
J Biol Chem 275:16002, 2000
25. Engel J et al: Structure and macromolecular organization of type VI
collagen.
Ann N Y Acad Sci 460:25, 1985
26. Timpl R, Chu M-L: Microfibrillar
collagen type VI. In:
Extracellular Matrix Assembly and Structure, edited by PD Yurchenco, DE Birk, RP Mecham. San Diego, Academic Press, 1994, p. 207
27. Lampe AK, Bushby KM:
Collagen VI related muscle disorders.
J Med Genet 42:673, 2005
28. Burgeson RE: Type VII
collagen, anchoring fibrils, and epidermolysis bullosa.
J Invest Dermatol 101:252, 1993
29. Chung HJ, Uitto J: Type VII
collagen: The anchoring fibril protein at fault in dystrophic epidermolysis bullosa.
Dermatol Clin 28:93, 2010
30. Bruckner-Tuderman L: Dystrophic epidermolysis bullosa: Pathogenesis and clinical features. Dermatol Clin 28:107, 2010
31. Varki R et al: Epidermolysis bullosa. II. Type VII
collagen mutations and phenotype-genotype correlations in the dystrophic subtypes.
J Med Genet 44:181, 2007
32. Shaw LM, Olsen BR: FACIT collagens: Diverse molecular bridges in extracellular matrices. Trends Biochem Sci 16:191, 1991
33. Marneros AG, Olsen BR: Physiological role of
collagen XVIII and endostatin.
FASEB J 19:716, 2005
34. Ortega N, Werb Z: New functional roles for non-collagenous domains of basement membrane collagens. J Cell Sci 115:4201, 2002
35. Franzke CW et al: Collagenous transmembrane proteins: Recent insights into biology and pathology. J Biol Chem 280:4005, 2005
36. Nonaka S et al: The extracellular domain of BPAG2 has a loop structure in the carboxy terminal flexible tail in vivo. J Invest Dermatol 115:889, 2000
37. Gatalica B et al: Cloning of the human type XVII
collagen gene (COL17A1), and detection of novel mutations in generalized atrophic benign epidermolysis bullosa.
Am J Hum Genet 60:352, 1997
38. Tasanen K et al: Keratinocytes from patients lacking
collagen XVII display a migratory phenotype.
Am J Pathol 164:2027, 2004
39. Stanley JR et al: Pemphigus antibodies identify a cell surface glycoprotein synthesized by human and mouse keratinocytes. J Clin Invest 70:281, 1982
40. Jonkman MF et al: 180-kD bullous pemphigoid antigen (BP180) is deficient in generalized atrophic benign epidermolysis bullosa. J Clin Invest 95:1345, 1995
41. Chu M-L, Prockop DJ:
Collagen: Gene structure. In:
Connective Tissue and Its Heritable Disorders: Molecular, Genetic and Medical Aspects, 2nd edition, edited by PM Royce, B Steinmann. New York, Wiley-Liss, 2002, p. 223
42. Myllylharju M: Prolyl-4-hydroxylases, the key enzymes of
collagen biosynthsis.
Matrix Biol 22:15, 2003
43. Krane SM: The importance of proline residues in the structure, stability and susceptibility to proteolytic degradation of collagens. Amino Acids 35:703, 2008
44. Gorres KL, Raines RT: Prolyl 4-hydroxylase. Crit Rev Biochem Mol Biol 45:106, 2010
45. Myllylä R et al: Expanding the lysyl hydroxylase toolbox: New insights into the localization and activities of lysyl hydroxylase 3 (LH3). J Cell Physiol 212:323, 2007
46. Davidson JM et al: Ascorbate differentially regulates elastin and
collagen biosynthesis in vascular smooth muscle cells and skin fibroblasts by pretranslational mechanisms.
J Biol Chem 272:345, 1997
47. Uitto J, Prockop DJ: Synthesis and secretion of under-hydroxylated procollagen at various temperatures by cells subject to temporary anoxia. Biochem Biophys Res Commun 60:414, 1974
48. Myllyharju J: HIF prolyl 4-hydroxylases and their potential as drug targets. Curr Pharm Des 15:3878, 2009
49. Berra E et al: The hypoxia-inducible-factor hydroxylases bring fresh air into hypoxia signalling. EMBO Rep 7:41, 2006
50. Robins SP: Biochemistry and functional significance of
collagen cross-linking.
Biochem Soc Trans 35:849, 2007
51. Salo AM et al: A connective tissue disorder caused by mutations of the lysyl hydroxylase 3 gene. Am J Hum Genet 83:495, 2008
52. Prockop DJ et al: Procollagen N-proteinase and procollagen C-proteinase. Two unusual metalloproteinases that are essential for procollagen processing probably have important roles in development and cell signaling. Matrix Biol 16:399, 1998
53. Apte SS: A disintegrin-like and metalloprotease (reprolysin-type) with thrombospondin type 1 motif (ADAMTS) superfamily: Functions and mechanisms. J Biol Chem 284:31493, 2009
54. Kessler E et al: Bone morphogenetic protein-1: The type I procollagen C-proteinase. Science 271:360, 1996
55. Takahara K et al: Type I procollagen COOH-terminal proteinase enhancer protein: identification, primary structure, and chromosomal localization of the cognate human gene (PCOLCE). J Biol Chem 269:26280, 1994
56. Colige A et al: Human Ehlers-Danlos syndrome type VII C and bovine dermatosparaxis are caused by mutations in the procollagen I N-proteinase gene. Am J Hum Genet 65:308, 1999
57. Byers PH et al: Ehlers-Danlos syndrome type VIIA and VIIB result from splice-junction mutations or genomic deletions that involve exon 6 in the COL1A1 and COL1A2 genes of type I
collagen.
Am J Med Genet 72:94, 1997
58. Rucker RB, Murray J: Cross-linking amino acids in
collagen and elastin.
Am J Clin Nutr 31:1221, 1978
59. Gasch AT et al: Menkes disease. Ophthalmology 106:442, 1999
60. Uitto J, Kouba D: Cytokine modulation of extracellular matrix gene expression: Relevance to fibrotic skin diseases. J Dermatol Sci 24:S60, 2000
61. Gabrielli A, Avvedimento EV, Krieg T: Scleroderma. N Engl J Med 360:1989, 2009
62. Karsenty G, Park RW: Regulation of type I
collagen genes expression.
Int Rev Immunol 12:177, 1995
63. Ramirez F et al: Transcriptional regulation of the human a2(I)
collagen gene (COL1A2), an informative model system to study fibrotic diseases.
Matrix Biol 25:365, 2006
64. Griffiths CE et al: Restoration of
collagen formation in photodamaged human skin by
tretinoin (retinoic acid).
N Engl J Med 329:530, 1993
65. Verrecchia F, Mauviel A: TGF-b and TNF-a: Antagonistic cytokines controlling type I
collagen gene expression.
Cell Signal 16:873, 2004
66. Ferreira AM et al: Diminished induction of skin fibrosis in mice with MCP-1 deficiency. J Invest Dermatol 126:1900, 2006
67. Nagase H, Woessner JF, Jr.: Matrix metalloproteinases. J Biol Chem 274:21491, 1999
68. Page-McCaw A et al: Matrix metalloproteinases and the regulation of tissue remodelling. Nat Rev Mol Cell Biol 8:221, 2007
69. Kessenbrock K et al: Matrix metalloproteinases: Regulators of the tumor microenvironment. Cell 141:52, 2010
70. Bode W, Maskos K: Structural basis of the matrix metalloproteinases and their physiological inhibitors, the tissue inhibitors of metalloproteinases. Biol Chem 384:863, 2003
71. Brew K, Nagase H: The tissue inhibitors of metalloproteinases (TIMPs): An ancient family with structural and functional diversity. Biochim Biophys Acta 1803:55, 2010
72. Gross J, Lapière CM: Collagenolytic activity in amphibian tissues: A tissue culture assay. Proc Natl Acad Sci USA 48:1014, 1962
73. Bauer EA et al:
Collagenase production by human skin fibroblasts.
Biochem Biophys Res Commun 64:232, 1975
74. Krane et al: Different
collagenase gene products have different roles in degradation of type I
collagen.
J Biol Chem 271:28509, 1996
75. Saffarian S et al: Interstitial
collagenase is a Brownian ratchet driven by proteolysis of
collagen.
Science 306:108, 2004
76. Midwood KS, Schwarzbauer JE: Elastic fibers: Building bridges between cells and their matrix. Curr Biol 12:R279, 2002
77. Kielty CM: Elastic fibres in health and disease. Expert Rev Mol Med 8:1, 2006
78. Uitto J et al: Elastic fibers in human skin: Quantitation of elastic fibers by computerized digital image analyses and determination of elastin by radioimmunoassay of desmosine. Lab Invest 49:499, 1983
79. Akagawa M, Suyama K: Mechanism of formation of elastin crosslinks. Connect Tissue Res 41:131, 2000
80. Sandberg LB, Davidson JM: Elastin and its gene. Pept Prot Rev 3:169, 1984
81. Fazio MJ et al: Cloning of full-length elastin cDNAs from a human skin fibroblast recombinant cDNA library: Further elucidation of alternative splicing utilizing exon-specific oligonucleotides. J Invest Dermatol 91:458, 1988
82. Bashir M et al: Characterization of the complete human elastin gene. J Biol Chem 264:8887, 1989
83. Fazio MJ et al: Isolation and characterization of human elastin cDNAs, and age-associated variation in elastin gene expression in cultured skin fibroblasts. Lab Invest 58:270, 1988
84. Indik Z et al: Alternative splicing of human elastin mRNA demonstrated by sequence analysis of cloned genomic and complementary DNA. Proc Natl Acad Sci U S A 84:5680, 1987
85. Kahari VM et al: Deletion analyses of 5′-flanking region of the human elastin gene. Delineation of functional promoter and regulatory cis-elements. J Biol Chem 265:9485, 1990
86. Hsu-Wong S et al: Tissue-specific and developmentally regulated expression of human elastin promoter activity in transgenic mice. J Biol Chem 269:18072, 1994
87. Hormuzdi SG et al: A gene-targeting approach identifies a function for the first intron in expression of the a1(I)
collagen gene.
Mol Cell Biol 18:3368, 1998
88. Kahari VM et al: Tumor necrosis factor-a down-regulates human elastin gene expression. Evidence for the role of AP-1 in the suppression of promoter activity. J Biol Chem 267:26134, 1992
89. Kahari VM et al: Transforming growth factor-b up-regulates elastin gene expression in human skin fibroblasts. Evidence for post-transcriptional modulation. Lab Invest 66:580, 1992
90. Pierce RA et al: 1,25-Dihydroxyvitamin D3 represses tropoelastin expression by a posttranscriptional mechanism. J Biol Chem 267:11593, 1992
91. Wolfe BL et al: Insulin-like growth factor-I regulates transcription of the elastin gene. J Biol Chem 268:12418, 1993
92. Giro MG et al: Quantitation of elastin production in cultured vascular smooth muscle cells by a sensitive and specific enzyme-linked immunoassay.
Collagen Rel Res 4:21, 1984
93. Rosenbloom J, Cywinski A: Inhibition of proline hydroxylation does not inhibit secretion of tropoelastin by chick aorta cells. FEBS Lett 65:246, 1976
94. Molnar J et al: Structural and functional diversity of lysyl oxidase and the LOX-like proteins. Biochim Biophys Acta 1647:220, 2003
95. Lucero HA, Kagan HM: Lysyl oxidase: An oxidative enzyme and effector of cell function. Cell Mol Life Sci 63:2304, 2006
96. Rucker RB: Isolation of soluble elastin from copper-deficient chick aorta. Methods Enzymol 82A:559, 1982
97. Kuivaniemi H et al: Abnormal
copper metabolism and deficient lysyl oxidase activity in a heritable connective tissue disorder.
J Clin Invest 69:710, 1983
98. Antonicelli F et al: Elastin-elastases and inflamm-aging. Curr Top Dev Biol 79:99, 2007
99. Uitto J: Biochemistry of the elastic fibers in normal connective tissues and its alterations in diseases. J Invest Dermatol 72:1, 1979
100. Werb Z et al: Elastase and elastin degradation. J Invest Dermatol 79:154s, 1982
101. Senior RM et al: Comparison of the elastolytic effects of human leukocyte elastase and porcine pancreatic elastase. Adv Exp Med Biol 79:249, 1977
102. Shapiro SD et al: Cloning and characterization of a unique elastolytic metalloproteinase produced by human alveolar macrophages. J Biol Chem 268:23824, 1993
103. Hubmacher D et al: Fibrillins: From biogenesis of microfibrils to signaling functions. Curr Top Dev Biol 75:93, 2006
104. Ramirez F, Sakai LY: Biogenesis and function of fibrillin assemblies. Cell Tissue Res 339:71, 2010
105. Ramirez F et al: Extracellular microfibrils in development and disease. Cell Mol Life Sci 64:2437, 2007
106. Jovanović J et al: Fibrillin-integrin interactions in health and disease. Biochem Soc Trans 36:257, 2008
107. Ramirez F, Rifkin DB. Extracellular microfibrils: Contextual platforms for TGFb and BMP signaling. Curr Opin Cell Biol 21:616, 2009
108. Rifkin DB: Latent transforming growth factor-beta (TGF-b) binding proteins: Orchestrators of TGF-b availability. J Biol Chem 280:7409, 2005
109. Hyytiäinen M et al: Latent TGF-b binding proteins: Extracellular matrix association and roles in TGF-b activation. Crit Rev Clin Lab Sci 41:233, 2004
110. Karonen T et al: Transforming growth factor b1 and its latent form binding protein-1 associate with elastic fibres in human dermis: Accumulation in actinic damage and absence in anetoderma. Br J Dermatol 137:51, 1997
111. Timpl R et al: Fibulins: A versatile family of extracellular matrix proteins. Nat Rev Mol Cell Biol 4:479, 2003.
112. de Vega S et al: Fibulins: Multiple roles in matrix structures and tissue functions. Cell Mol Life Sci 66:1890, 2009
113. McLaughlin PJ et al: Targeted disruption of fibulin-4 abolishes elastogenesis and causes perinatal lethality in mice. Mol Cell Biol 26:1700, 2006
114. Nakamura T et al: Fibulin-5/DANCE is essential for elastogenesis in vivo. Nature 415:171, 2002
115. Yanagisawa H et al: Fibulin-5 is an elastin-binding protein essential for elastic fibre development in vivo. Nature 415:168, 2002
116. Loeys B et al: Homozygosity for a missense mutation in fibulin-5 (FBLN5) results in a severe form of cutis laxa. Hum Mol Genet 11:2113, 2002
117. Markova D et al: Genetic heterogeneity of cutis laxa: A heterozygous tandem duplication within the fibulin-5 (FBLN5) gene. Am J Hum Genet 72:998, 2003
118. Hucthagowder V et al: Fibulin-4: A novel gene for an autosomal recessive cutis laxa syndrome. Am J Hum Genet 78:1075, 2006
119. Colombatti A et al: The EMILIN protein family. Matrix Biol 19:289, 2000
120. Wagenseil J, Mecham RP: New insights into elastic fiber assembly. Birth Defects Res C Embryo Today 81:229, 2007
121. Esko JD, Lindahl U: Molecular diversity of heparan sulfate. J Clin Invest 108:169, 2001
122. Esko JD et al: Proteoglycans and sulfated glycosaminoglycans. In: Essentials of Glycobiology, 2nd edition, edited by A Varki, RD Cummings, JD Esko, HH Freeze, P Stanley, CR Bertozzi, GW Hart, ME Etzler. Cold Spring Harbor, NY, Cold Spring Harbor Laboratory Press, 2009. Chapter 16
123. Kolset SO, Tveit H: Serglycin–Structure and biology. Cell Mol Life Sci 65:1073, 2008
124. Bernfield et al: Functions of cell surface heparan sulphate proteoglycans. Annu Rev Biochem 68:729, 1999
125. Fransson LA et al: Biosynthesis of decorin and glypican. Matrix Biol 19:367, 2000
126. David G: Integral membrane heparan sulfate proteoglycans. FASEB J 7:1023, 1993
127. Lundqvist K, Schmidtchen A: Immunohistochemical studies on proteoglycan expression in normal skin and chronic ulcers. Br J Dermatol 144:254, 2001
128. Multhaupt HA et al: Syndecan signaling: When, where and why? J Physiol Pharmacol 60:31, 2009
129. Lambaerts K et al: The signaling mechanisms of syndecan heparan sulfate proteoglycans. Curr Opin Cell Biol 21:662, 2009
130. Rapraeger
AC: Molecular interactions of syndecans during development.
Semin Cell Dev Biol 12:107, 2001
131. Sanderson RD et al: Syndecan-1, a cell-surface proteoglycan, changes in size and abundance when keratinocytes stratify. J Invest Dermatol 99:390, 1992
132. Gallo R et al: Syndecans-1 and -4 are induced during wound repair of neonatal but not fetal skin. J Invest Dermatol 107:676, 1996
133. Inki P, Jalkanen M: The role of syndecan-1 in malignancies. Ann Med 28:63, 1996
134. Hirabayashi K et al: Altered proliferative and metastatic potential associated with increased expression of syndecan-1. Tumour Biol 19:454, 1998
135. Gallagher JT: The extended family of proteoglycans: Social residents of the pericellular zone. Curr Opin Cell Biol 1:1201, 1989
136. Kinsella MG et al: The regulated synthesis of versican, decorin, and biglycan: Extracellular matrix proteoglycans that influence cellular phenotype. Crit Rev Eukaryot Gene Expr 14:203, 2004
137. Tiedemann K et al: Cytokine regulation of proteoglycan production in fibroblasts: Separate and synergistic effects. Matrix Biol 15:469, 1997
138. Keene DR et al: Decorin binds near the C terminus of type I
collagen.
J Biol Chem 275:21801, 2000
139. Elefteriou F et al: Binding of tenascin-X to decorin. FEBS Lett 495:44, 2001
140. Danielson KG et al: Targeted disruption of decorin leads to abnormal
collagen fibril morphology and skin fragility.
J Cell Biol 136:729, 1997
141. Iozzo RV: Basement membrane proteoglycans: From cellar to ceiling. Nat Rev Mol Cell Biol 6:646, 2005
142. Ornitz DM, Itoh N: Fibroblast growth factors. Genome Biol 2:S3005, 2001
143. Loo BM, Salmivirta M:
Heparin/Heparan sulfate domains in binding and signaling of fibroblast growth factor 8b.
J Biol Chem 277:32616, 2002
144. Sergeant N et al: Stimulation of DNA synthesis and cell proliferation of human mammary myoepithelial-like cells by hepatocyte growth factor/scatter factor depends on heparan sulfate proteoglycans and sustained phosphorylation of mitogen-activated protein kinases p42/44. J Biol Chem 275:17094, 2000
145. Tessler S et al:
Heparin modulates the interaction of VEGF165 with soluble and cell associated flk-1 receptors.
J Biol Chem 269:12456, 1994
146. Pellegrini L et al: Crystal structure of fibroblast growth factor receptor ectodomain bound to ligand and
heparin.
Nature 407:1029, 2000
147. Jiang D et al: Hyaluronan in tissue injury and repair. Annu Rev Cell Dev Biol 23:435, 2007
148. Leitinger B, Hohenester E: Mammalian
collagen receptors.
Matrix Biol 26:146, 2007
149. Dogic D, Eckes B, Aumailley M: Extracellular matrix, integrins and focal adhesions. Curr Top Pathol 93:75, 1999
150. Watt F: Role of integrins in regulating epidermal adhesion, growth and differentiation. EMBO J 21:3919, 2002
151. Larsen M et al: The matrix reorganized: Extracellular matrix remodeling and integrin signaling. Curr Opin Cell Biol 18:463, 2006
152. Barczyk M et al: Integrins. Cell Tissue Res 339:269, 2010
153. Eckes B et al: Mechanical tension and integrin a2b1 regulate fibroblast functions. J Investig Dermatol Symp Proc 11:66, 2006.
154. Zollner TM et al: Targeting leukocyte trafficking to inflamed skin: Still an attractive therapeutic approach? Exp Dermatol 16:1, 2007
155. Margadant C, Sonnenberg A: Integrin–TGF-β crosstalk in fibrosis, cancer and wound healing. EMBO Rep 11:97, 2010
156. Ramirez F, Dietz HC: Extracellular microfibrils in vertebrate development and disease processes. J Biol Chem 284:14677, 2009
157. Brooke BS et al: Angiotensin II blockade and aortic-root dilation in Marfan's syndrome. N Engl J Med 358:2787, 2008
158. Brown EL et al: Resistance to Lyme disease in decorin-deficient mice. J Clin Invest 107:845, 2001
159. Carrino DA et al: Age-related changes in the proteoglycans of human skin. Arch Biochem Biophys 373:91, 2000
160. Ghersetich I et al: Hyaluronic acid in cutaneous intrinsic aging. Int J Dermatol 33:119, 1994
161. Lundin A et al: Topical retinoic acid treatment of photoaged skin: Its effects on hyaluronan distribution in epidermis and on hyaluronan and retinoic acid in suction blister fluid. Acta Derm Venereol 72:423, 1992
162. Alaish SM et al: Hyaluronic acid metabolism in keloid fibroblasts. J Pediatr Surg 30:949, 1995
163. Lamandé SR et al: Endoplasmic reticulum-mediated quality control of type I
collagen production by cells from osteogenesis imperfecta patients with mutations in the proα1 (I) chain carboxyl-terminal propeptide which impair subunit assembly.
J Biol Chem 270:8642, 1995
164. Pace JM et al: A single amino acid substitution (D1441Y) in the carboxyl-terminal propeptide of the proα1(I) chain of type I
collagen results in a lethal variant of osteogenesis imperfecta with features of dense bone diseases.
J Med Genet 39:23, 2002
165. Firtina Z et al: Abnormal expression of
collagen IV in lens activates unfolded protein response resulting in cataract.
J Biol Chem 284:35872, 2009
166. Lin JH et al: Endoplasmic reticulum stress in disease pathogenesis. Annu Rev Pathol 3:399, 2008
167. Bateman JF et al: Genetic diseases of connective tissues: Cellular and extracellular effects of ECM mutations. Nat Rev Genet 10:173, 2009
168. Boot-Handford RP, Briggs MD: The unfolded protein response and its relevance to connective tissue diseases. Cell Tissue Res 339:197, 2010